RSS Feeds
Search

Deals review


Innovaro Pharmalicensing categorizes news stories by company. If you cannot find what you are looking for below, try using our news search facility.

Headlines

Found 65 stories.

May 16 2006Boehringer Ingelheim signs a licence agreement with XstalBio for its protein formulation and drug delivery technology
Feb 15 2006Eli Lilly and Company and Boehringer Ingelheim announce changes to their contractual agreements for Yentreve®/AriClaim®
Jan 20 2006Boehringer Ingelheim licenses results from Target Discovery collaboration with Galapagos
Nov 03 2005Boehringer Ingelheim extends scope of collaboration with Evotec into screening services
Oct 21 2005Syntonix and Boehringer Ingelheim enter collaboration for up to $63 million to optimize therapeutic peptide candidates for inhalation
Aug 31 2005Astex announces new drug discovery collaboration with Boehringer Ingelheim
Jul 28 2005Nippon Boehringer Ingelheim to consolidate marketing of"Alesion" in joint agreement with Sankyo
Jul 12 2005Caprion Pharmaceuticals announces biomarker research collaboration with Boehringer Ingelheim
Jun 16 2005Avantium Technologies and Boehringer Ingelheim enter into collaboration on selected pharmaceutical compounds.
Jun 06 2005Boehringer Ingelheim and AbGenomics Corporation sign worldwide exclusive collaboration and license agreement to develop and commercialize a therapeutic monoclonal antibody
May 16 2005Corautus Genetics Inc. enters into long term manufacturing agreement with Boehringer Ingelheim Austria GmbH for production of VEGF-2 plasmid DNA
Apr 01 2005Ark Grants Licence to Boehringer Ingelheim for Access to Key Technology
Mar 18 2005Boehringer Ingelheim and MorphoSys Enlarge Collaboration
Mar 04 2005NIR DIAGNOSTICS COMPLETES SUPPLY AGREEMENT FOR HemoNIR™
Feb 16 2005Boehringer Ingelheim and NascaCell announce research collaboration on aptamers
Feb 09 2005ImmunoGen, Inc. Provides Update on Collaboration with Boehringer Ingelheim
Jan 31 2005Boehringer Ingelheim Pharmaceuticals Inc. and BioImage sign licensing deal on Redistribution® Technology
Jan 28 2005Lilly and Boehringer Ingelheim Jointly Announce the decision of U.S. FDA Application for Duloxetine for Treatment of Stress Urinary Incontinence
Nov 29 2004Avidia Research Institute and Boehringer Ingelheim Austria enter development and manufacturing agreement
Sept 15 2004Boehringer Ingelheim to acquire STEAG microParts GmbH in Germany
Sept 08 2004Evotec OAI and Evotec Neurosciences enter into Joint Drug Discovery Collaboration with Boehringer Ingelheim to identify GPCR Modulator-based new medicines
Aug 16 2004MorphoSys and Boehringer Ingelheim Start New Antibody Program
Aug 16 2004Yamanouchi Concludes Co-promotion Agreement with US Boehringer Ingelheim for FLOMAX® for the Treatment of Functional Symptoms of Benign Prostatic Hyperplasia
Jul 12 2004Boehringer Ingelheim and GlaxoSmithKline to develop co-package of Viramune® and Combivir® for the developing world
May 17 2004Nippon Boehringer Ingelheim and Daiichi Pharmaceutical Agree to Consolidate MOBIC Marketing in Japan to Daiichi Pharmaceutical's Expertise
May 17 2004Nippon Boehringer Ingelheim and Daiichi Pharmaceutical Agree to Consolidate MOBIC Marketing in Japan to Daiichi Pharmaceutical's Expertise
Dec 22 2003Chiron grants nonexclusive HCV license to Boehringer Ingelheim
Nov 20 2003Boehringer Ingelheim exercises option in MorphoSys collaboration
Jul 16 2003Boehringer Ingelheim, Medivir sign license deal
Mar 11 2003NeuroSearch and Boehringer Ingelheim initiate Phase II clinical
Feb 26 2003MorphoSys, Boehringer agree collaboration
Feb 26 20034SC and Boehringer sign research agreement
Jan 21 2003Merial and Boehringer Ingelheim Vetmedica announce alliance
Jan 16 2003Structural GenomiX, Boehringer Ingelheim form collaboration
Jan 16 2003Boehringer Ingelheim in collaboration with Sagres Discovery
Dec 06 2002Lilly and Boehringer Ingelheim sign commercialization agreement
Dec 04 2002Kissei licenses novel therapeutic compound
Sept 18 2002Therion Biologics licenses ICAM-1 from Boehringer Ingelheim
Sept 09 2002SPIRIVA recommended for approval
Jul 11 2002Boehringer Ingelheim and Genetronics sign agreement
Dec 19 2001B.Ingelheim and Structural Bioinformatics Collaborate On Anti-HIV
Nov 29 2001Boehringer Ingelheim and ImmunoGen sign license agreement
Oct 17 2001InterMune, Boehringer Ingelheim expand partnership
Oct 03 2001Pharmacopeia and Boehringer Ingelheim agree collaboration
Aug 06 2001Boehringer accesses Cellomics'HCS technologies
Jun 22 2001Genetronics and Boehringer Sign Agreement
May 27 2001Mobic has Favourable Safety Profile
Apr 30 20013-Dimensional and Boehringer Ingelheim Extend Drug Discovery Collaboration
Apr 17 2001Boehringer Ingelheim and Pfizer sign marketing agreement
Feb 27 2001Message Pharmaceuticals and Boehringer agree research collaboration
Feb 08 2001Phase-1 Molecular Toxicology to develop diagnostic technologies
Jan 10 2001GPC Biotech and Boehringer sign genomics and proteomics alliance
Sept 27 2000Variagenics and Boehringer sign pharmacogenomics agreement
May 19 2000Purdue defends sustained release Oxycodone patent position
Apr 10 2000Atugen announces target validation collaboration with Boehringer Ingelheim
Apr 05 2000Nutraceutix Licenses Subsidiary of Boehringer-Ingelheim to Market Calcium D-Glucarate
Feb 11 2000Biofocus and Boehringer Ingelheim enter lead optimisation agreement
Jan 09 2000Phase-1 In Research Collaboration with Boehringer Ingelheim
Dec 23 1999Allergan in-licenses allergy compound
Dec 10 1999Boehringer Ingelheim and Vion restructure license agreement
Nov 10 1999Genetronics and Boehringer Ingelheim agree research collaboration
Oct 16 1999US Parkinson's Disease study shows significant benefit
Sept 21 1999Valentis and Boehringer Ingelheim to collaborate on rheumatoid arthritis therapy
Aug 30 1999Embrex and Boehringer Ingelheim agree vaccine collaboration
Aug 14 1999Boehringer Ingelheim and Abbott Laboratories to co-promote benignprostatic hyperplasia treatment in US

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2010 Innovaro Europe Ltd Innovaro Corporation All rights reserved. Terms and Conditions | Contact us